CardioCell Reports Positive Results From the First Phase IIa Clinical Trial Using IV Administration of Stem Cells for Chronic Heart Failure Indications; "Hot Line" Late-Breaking Session at European Society of Cardiology (ESC) Reveals Data Showing Improvem

Press/Media: Press / Media

PeriodAug 28 2016

Media coverage

4

Media coverage

  • TitleCardioCell Reports Positive Results From the First Phase IIa Clinical Trial Using IV Administration of Stem Cells for Chronic Heart Failure Indications; "Hot Line" Late-Breaking Session at European Society of Cardiology (ESC) Reveals Data Showing Improvem
    Media name/outletPR Newswire
    CountryUnited States
    Date8/28/16
    PersonsAllen S Anderson
  • TitleCardioCell Reports Positive Results From the First Phase IIa Clinical Trial Using IV Administration of Stem Cells for Chronic Heart Failure Indications; "Hot Line" Late-Breaking Session at European Society of Cardiology (ESC) Reveals Data Showing Improvem
    Media name/outletPR Newswire
    CountryUnited States
    Date8/28/16
    PersonsAllen S Anderson
  • TitleCardioCell Reports Positive Results From the First Phase IIa Clinical Trial Using IV Administration of Stem Cells for Chronic Heart Failure Indications; "Hot Line" Late-Breaking Session at European Society of Cardiology (ESC) Reveals Data Showing Improvem
    Media name/outletPR Newswire
    CountryUnited States
    Date8/28/16
    PersonsAllen S Anderson
  • TitleCardioCell Reports Positive Results From the First Phase IIa Clinical Trial Using IV Administration of Stem Cells for Chronic Heart Failure Indications; "Hot Line" Late-Breaking Session at European Society of Cardiology (ESC) Reveals Data Showing Improvem
    Media name/outletPR Newswire
    CountryUnited States
    Date8/28/16
    PersonsAllen S Anderson